Planet 13 Holdings (PLNH) Other Non-Current Liabilities (2021 - 2026)

Planet 13 Holdings' (PLNH) quarterly Other Non-Current Liabilities came in at $1.3 million in Q1 2026, down 93.45% year-on-year from $19.3 million in Q1 2025, and down 96.17% on a QoQ basis from $33.0 million in Q4 2025.

Planet 13 Holdings (PLNH) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 6 years of Other Non-Current Liabilities data on file, last reported at $1.3 million in Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 93.45% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 93.45% decrease from a year earlier, with the FY2025 full-year figure at $33.0 million, up 71.01% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $1.3 million, down from $33.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for PLNH reached as high as $33.0 million in Q4 2025 and fell as low as $28000.0 in Q1 2022.
  • Historically, Other Non-Current Liabilities has averaged $7.2 million across 5 years, with a median of $33000.0 in 2024.
  • Across the five-year window, Other Non-Current Liabilities slumped 99.61% in 2022 and surged 81421.93% in 2025, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $28000.0 in 2022, then changed by 0.0% to $28000.0 in 2023, then soared by 68905.27% to $19.3 million in 2024, then soared by 71.01% to $33.0 million in 2025, then slumped by 96.17% to $1.3 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.3 million in Q1 2026, $33.0 million in Q4 2025, and $1.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Planet 13 Holdings 39.35 Mn 23.09 Mn 9.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.27 Mn
Dec 31, 2025 33.04 Mn
Sep 30, 2025 1.26 Mn
Jun 30, 2025 26.90 Mn
Mar 31, 2025 19.32 Mn
Dec 31, 2024 19.32 Mn
Sep 30, 2024 33,000.00
Jun 30, 2024 33,000.00
Mar 31, 2024 33,000.00
Jun 30, 2023 28,000.00
Mar 31, 2023 28,000.00
Sep 30, 2022 28,000.00
Jun 30, 2022 28,000.00
Mar 31, 2022 28,000.00
Dec 31, 2021 28,000.00
Mar 31, 2021 7.21 Mn